DURHAM, N.C., Oct. 22, 2015 /PRNewswire/ -- Schulman IRB, the industry-leading central IRB in customer service and technology, is pleased to announce its new office in the Research Triangle Park, Durham, North Carolina, is hosting an open house on Tuesday, October 27.
"We're excited to open our doors to the research community," said Michael Woods, President, CEO and Institutional Official at Schulman. "Now that we have settled into our space, we want to welcome our new neighbors to meet the team and celebrate with us. Since breaking ground in June, we've all anticipated this day, and we are delighted to show everyone our new business home."
Schulman's RTP space features state-of-the-art communication technology infrastructure, enabling robust and efficient discussions among Schulman's diverse board membership, whose locations are spread across the continent. The technology hub helps Schulman staff communicate rapidly with clients and others within the organization in its unwavering commitment to deliver exceptional customer service.
Located at 10 Laboratory Drive, Schulman will be welcoming guests at 4:30, with a ribbon cutting and dedication ceremony beginning at 5:30pm. Attendees will enjoy light snacks and beverages and have a chance to win one of two $150 gift certificates to Angus Barn.
To attend the event, register at schulmanirbopenhouse.eventbrite.com.
About Schulman IRB
Schulman IRB has been a leader in the protection of human research participants in the U.S., Puerto Rico and Canada since 1983. Schulman offers thorough, timely IRB review services – including dedicated review capabilities for all phases of research across all therapeutic areas – to clinical trial sponsors, CROs, investigators and institutions. Schulman also provides global consulting services through its joint venture partner Provision Research Compliance Services, offering comprehensive solutions to improve overall quality standards for clinical studies and data integrity, and to maximize the protection of human subjects. Fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), Schulman has an unparalleled clean audit history with the Food and Drug Administration (FDA).
SOURCE Schulman Associates IRB